A. C. Lankester
University of Amsterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. C. Lankester.
Immunology Today | 1993
Carel J. M. van Noesel; A. C. Lankester; RenéA.W. van Lier
Foreign antigens opsonized by complement degradation products may be bound by both the B-cell antigen receptor (BCR) and CR2-CD19 complexes. Under these circumstances, the extensive cytoplasmic tail of CD19 endows the BCR with additional tyrosine kinase activity and with potential docking sites for molecules involved in cell signalling. Here, Carel van Noesel and colleagues argue that cooperation between BCR and CR2-CD19 at both the extra- and intracellular level provide for optimal recognition of antigen and amplification of ensuing intracellular signals.
Leukemia & Lymphoma | 1996
A. C. Lankester; Gijs M.W. van Schijndel; Nadine G. Pakker; Rien H. J. van Oers; René A. W. van Lier
Functional studies revealed that two groups of B chronic lymphocytic leukemia (B-CLL) can be distinguished based on their capacity to mount a proliferative response following B-cell antigen receptor (BCR) cross-linking. The molecular basis for the functional distinction between these B-CLL groups most probably resides within or proximal to the BCR since non-responsive B-CLL, in marked contrast to responsive B-CLL, do not respond to BCR ligation with tyrosine phosphorylation of cellular substrates and increases in the free intracellular [Ca++]. Detailed biochemical analysis showed overall structural identity between responsive and non-responsive B-CLL with respect to both transmembrane and intracellular associates of the BCR complex. However expression levels of the protein tyrosine kinase syk, which is a key enzyme for the early signalling through the BCR, were found to be markedly lower in non-proliferating B-CLL. Here we will review current functional and biochemical data on responding and non-responding B-CLL and discuss the relevance of these findings for disease progression and our insight into the immunobiology of B-CLL.
Immunology Letters | 1997
M.M. Maurice; A. C. Lankester; A.C. Bezemer; M.F. Geertsma; Paul P. Tak; Ferdinand C. Breedveld; R. A. W. Van Lier; Cornelis L. Verweij
In rheumatoid arthritis (RA), the functional status of T cells is incompletely understood. Synovial T cells display phenotypic evidence of former activation, but there is poor production of T cell-derived cytokines in the synovium. In addition, synovial T cell proliferation upon mitogenic and antigenic stimulation was decreased compared with that in peripheral blood T cells. Moreover, previous reports revealed that early Ca2+ rises induced by TCR/CD3 stimulation were decreased in RA T cells compared with those in healthy controls. To investigate the molecular mechanisms of RA synovial T cell hyporesponsiveness, we analyzed the TCR/CD3-mediated protein tyrosine phosphorylation in RA peripheral blood and synovial fluid (SF) T cells. SF T cells exhibited a decreased overall tyrosine phosphorylation pattern upon stimulation. Most notably, the induction of phosphorylation of p38 was virtually absent. Moreover, we found that tyrosine phosphorylation of the TCR zeta-chain, one of the most proximal events in TCR signaling, is clearly diminished in RA SF T cells. The decrease in tyrosine phosphorylation was accompanied by a decrease in detectable levels of zeta-protein within synovial T cells. These results suggest that a defective TCR signaling underlies the hyporesponsiveness of synovial T cells in RA.
Molecular Immunology | 1996
A. C. Lankester; RenéA.W. van Lier
Receptor tyrosine kinases (RTK), like the PDGF-receptor, translate information from the extracellular environment into cytoplasmic signals that regulate a spectrum of cellular functions. RTK molecules consist of ligand binding extracellular domains, cytoplasmic kinase domains and tyrosine phosphorylation sites [Ullrich and Schlessinger, 1990 (Cell 61, 203-212); Heldin, 1992 (EMBO J. 11, 4251-4259)]. Upon ligand-induced RTK oligomerization, the kinase domains will become activated and induce auto(trans)phosphorylation of a number of cytoplasmic tyrosine residues. These phosphorylated tyrosine residues are incorporated in distinct sequence motifs and act as specific docking sites for SH2 domain-containing proteins [Songyang et al., 1993 (Cell 72, 767-778)]. In contrast to single- or oligo-chain RTK, immunological receptors such as antigen receptors, FcR and cytokine receptors are multi-chain complexes in which distinct receptor functions appear to be compartmentalized in distinct polypeptides. Here, we summarize current knowledge on the structural and functional characteristics of the B-cell antigen receptor complex (BCR) and address the specific ability of accessory molecules to recruit intracellular signaling intermediates towards the activated receptor complex.
Journal of Immunology | 1997
Madelon M. Maurice; A. C. Lankester; A.C. Bezemer; M.F. Geertsma; Paul P. Tak; Ferdinand C. Breedveld; R. A. W. Van Lier; Cornelis L. Verweij
Blood | 1995
A. C. Lankester; G. M. W. Van Schijndel; C. E. Van Der Schoot; M. H. J. Van Oers; C. J. M. Van Noesel; R. A. W. Van Lier
European Journal of Immunology | 1994
A. C. Lankester; Gijs M.W. van Schijndel; Jacqueline L. Cordell; Carel J. M. van Noesel; René A. W. van Lier
International Immunology | 1993
Carel J. M. van Noesel; A. C. Lankester; Gijs M.W. van Schijndel; René A. W. van Lier
Journal of Biological Chemistry | 1995
A. C. Lankester; G. M. W. Van Schijndel; R. A. W. Van Lier
European Journal of Immunology | 1994
A. C. Lankester; Gijs M.W. van Schijndel; Pauline M. L. Rood; Arthur J. Verhoeven; René A. W. van Lier